Table 2.
Cancer site | Stomach | Colorectal | Liver | Lung | Thyroid | |||||
---|---|---|---|---|---|---|---|---|---|---|
Biennial follow-up surveys (definition 1) | ||||||||||
Eligible womena | 14,984 | 14,984 | 15,016 | 15,010 | 14,981 | |||||
Self-reported diagnosis = yes (potential incident cases) [% among eligible women] | 72 | [0.5%] | 136 | [0.9%] | 12 | [0.1%] | 83 | [0.6%] | 99 | [0.7%] |
Withdraw/lost of follow-up/death | 2 | 5 | 1 | 4 | 6 | |||||
Proceed to the additional outcome surveys [% among potential incident cases] | 70 | [97.2%] | 131 | [96.3%] | 11 | [91.7%] | 79 | [95.2%] | 93 | [93.9%] |
Additional outcome survey (definition 2) | ||||||||||
Eligible women | 70 | 131 | 11 | 79 | 93 | |||||
Responded [%]c | 64 | [91.4%] | 117 | [89.3%] | 9 | [81.8%] | 65 | [82.3%] | 76 | [81.7%] |
Self-reported diagnosis = yes [% among respondents] | 53 | [82.8%] | 109 | [93.2%] | 8 | [88.9%] | 57 | [87.7%] | 64 | [84.2%] |
Self-reported diagnosis = no | 9 | 7 | 1 | 8 | 11 | |||||
Self-reported diagnosis = unknown | 2 | 1 | 0 | 0 | 1 | |||||
Agreed on the medical facility survey [% among respondents] | 27 | [50.9%] | 49 | [45.0%] | 2 | [25.0%] | 29 | [50.9%] | 37 | [57.8%] |
Medical facility survey (definition 3) | ||||||||||
Eligible women | 27 | 49 | 2 | 29 | 37 | |||||
Responded [%]c | 20 | [74.1%] | 33 | [67.3%] | 0 | [0.0%] | 22 | [75.9%] | 32 | [86.5%] |
Physician-reported diagnosis = yes [% among respondents] | 20 | [100.0%] | 32 | [97.0%] | 0 | (NA) | 19 | [86.4%] | 31 | [96.9%] |
Death certificate | ||||||||||
Death from cancer during the follow-upb | 7 | 6 | 2 | 10 | 2 | |||||
Self-reported diagnosis at follow-up = yes | 5 | 3 | 0 | 6 | 2 | |||||
Death certificate only | 2 | 3 | 2 | 4 | 0 | |||||
Overall decision by Validation Study Committee (definition 4) | ||||||||||
Eligible women (=potential incident cases) | 72 | 136 | 12 | 83 | 99 | |||||
Diagnosis = yes [% among potential cases] | 58 | [80.6%] | 93 | [68.4%] | 7 | [58.3%] | 54 | [65.1%] | 64 | [64.6%] |
[% among all eligible women] | [0.4%] | [0.6%] | [0.05%] | [0.4%] | [0.4%] |
JNHS: Japan Nurses' Health Study, NA: not applicable; a. Eligible women were cohort members without a self-reported diagnosis of each disease at baseline (total cohor menbers: N=15,019); b, As of Apr. 30, 2019; c, As of Jul. 31, 2019